Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Infusion phlebitis associated with a programmable syringe-pump system versus gravity-feed minibottles.

R J Baptista1, D F Driscoll, J A Gallagher

  • 1Deaconess Home Health Care, Boston, MA 02215.

Clinical Pharmacy
|April 1, 1987
PubMed
Summary

A new syringe-pump system for intravenous antibiotics showed similar infusion phlebitis rates compared to traditional minibottle systems. This finding suggests comparable safety for peripheral IV catheter sites when using appropriate diluents and infusion parameters.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Joint replacement risk is markedly increased in alkaptonuria (AKU) in those with prior arthroplasty.

Molecular genetics and metabolism reports·2024
Same author

Hepatobiliary circulation and dominant urinary excretion of homogentisic acid in a mouse model of alkaptonuria.

Journal of inherited metabolic disease·2024
Same author

Lessons Learned from Contact Tracing COVID-19 cases in Dental Settings in East Scotland.

Community dental health·2024
Same author

A Health Inequalities Impact Assessment of the surveillance of COVID-19 in asymptomatic patients attending dental settings in Scotland.

Community dental health·2022
Same author

Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria.

Scientific reports·2022
Same author

Temporal adaptations in the phenylalanine/tyrosine pathway and related factors during nitisinone-induced tyrosinaemia in alkaptonuria.

Molecular genetics and metabolism·2022

Area of Science:

  • Medical devices
  • Pharmacology
  • Nursing

Background:

  • Infusion phlebitis is a common complication of intravenous therapy.
  • Traditional gravity-feed minibottle systems are widely used for antibiotic administration.
  • Novel syringe-pump systems offer potential advantages in medication delivery accuracy and control.

Purpose of the Study:

  • To compare the incidence and severity of infusion phlebitis between a syringe-pump system and a gravity-feed minibottle system for intravenous antibiotic administration.
  • To evaluate the safety and efficacy of a new medication delivery system in a clinical setting.

Main Methods:

  • A randomized study comparing a syringe-pump system with a gravity-feed minibottle system for intravenous antibiotic infusions.
  • Patients received antibiotics diluted in specified solutions (dextrose, saline, or sterile water) via peripheral intravenous catheters.

Related Experiment Videos

  • Catheter sites were monitored by i.v. nurse specialists for phlebitis using standardized criteria, with interventions based on phlebitis grade or duration.

    • Main Results:

    • A total of 85 catheter sites were evaluated over 18 weeks (53 in the syringe-pump group, 32 in the minibottle group).
    • The mean catheter life was approximately 50.6 hours in both groups.
    • Phlebitis occurred in 62% of syringe-pump sites and 66% of minibottle sites, with no significant difference in incidence or severity.

    Conclusions:

    • The syringe-pump system demonstrated a similar potential for causing infusion phlebitis compared to the gravity-feed minibottle system.
    • Appropriate selection of diluents, diluent volumes, and infusion rates are crucial for minimizing phlebitis risk with both systems.
    • The findings support the use of syringe-pump systems as a viable alternative for intravenous antibiotic delivery with comparable safety regarding phlebitis.